| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6115372 | Current Opinion in Immunology | 2011 | 8 Pages |
Abstract
MHC class II molecules (MHC-II) present antigenic fragments acquired in the endocytic route to the immune system for recognition and activation of CD4+ T cells. This ignites a series of immune responses. MHC-II strongly correlates to most autoimmune diseases. Understanding the biology of MHC-II is therefore expected to translate into novel means of autoimmunity control or immune response improvement. Although the basic cell biology of MHC-II antigen presentation is well understood, many novel aspects have been uncovered in recent years including means of antigen delivery, preparation for MHC-II loading, transport processes and vaccination strategies. We will discuss past, present and future of these insights into the biology of MHC-II.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Tineke van den Hoorn, Petra Paul, Marlieke LM Jongsma, Jacques Neefjes,